An overview of Switzerland’s pharmaceuticals industry

Posting date: 12 August 2019
The pharmaceutical industry employs 135,000 people in Switzerland and contributes to 30% of its exports — more than the Swiss chocolate, cheese and watches export industries combined, making it a significant economic industry for the nation. It’s no surprise with Switzerland’s forward-thinking and innovative endeavours that two of the world’s leading pharmaceutical companies, Novartis and Roche, are companies born out of Switzerland.

Other famous corporations in pharmaceuticals also employ heavily in Switzerland, including Celgene which ranks eighth in terms of its number of employees in Switzerland. Celgene has recently been acquired by Bristol-Myers Squibb for $74 billion, making it one of the top 10 most expensive mergers and acquisitions in history.

So why have these pharmaceutical giants chosen Switzerland as an attractive location to set base and how is it significant to their success? Let’s consider the pharmaceutical industry in Switzerland and why it’s such a key player in the global market.

Focus on speciality chemicals

Despite Switzerland’s lack of natural resources, it still hosts a successful export industry due to its focus on low volume speciality chemicals which constitutes 90% of its product portfolio. Switzerland is known for providing bespoke pharmaceutical solutions through its access to and funding for intensive research and development of these fine chemicals. The global demand for these speciality chemicals is always increasing, which makes Switzerland’s assets valuable.

Switzerland has seen many success stories and inventions in the pharmaceutical industries. Roche is credited with inventing Invirase, the world’s first HIV proteinase inhibitor drug in 1995 and later, co-created Funzeon, which stops the HIV virus from entering human cells. In addition, Novartis has been widely recognised for their work on cancer treatment through their aromatase blocker letrozole (Femara) which is used in the treatment of early-stage breast cancer.

The Swiss pharmaceutical industry now offers more than 30,000 products and is well-positioned to make significant contributions to healthcare, both in Switzerland and worldwide.

Intense research and development

From as early as 1896, the region of Basel became the centre of 19th-century pharmaceutical industries since Switzerland had no patent laws. This was in direct contrast with the surrounding European countries and led to a migration of researchers to Switzerland who wished to work without restrictions. Currently, there are 900 pharmaceutical and MedTech companies which employ 50,000 workers in the region of Basel. Though patent laws have changed since the 1890s, Switzerland still hosts a supportive regulatory environment through its fair patent and pricing regulations.

In addition, Switzerland’s current proximity to research institutions and sophisticated healthcare system provides an ideal environment for the intensive research of highly specialised products and the ability to test drugs to be sent to market.

There is also high access to recruit highly qualified scientists from these globally ranking universities and their research teams. Novartis hired 23,000 science professionals including scientists and doctors to work on over 200 projects in clinical development worldwide, just as Roche employed 22,000 people to work in research and development. Switzerland hosts outstanding scientific and technological workforce with in-demand skills.

In addition, there is a lot of financial support from pharmaceutical companies who have invested almost 7 billion Swiss francs into research and development in Switzerland.

Supportive framework conditions

Switzerland has free trade agreements with the EU and 40 other countries, including innovative key giants such as China and Japan which provide access to essential export markets. After Germany and China, Switzerland has the third most populated network of bilateral investment protection agreements.

Switzerland’s pharmaceutical industry is supported by its global reputation for high-quality production standards, for being a strategic test marketer and being able to introduce new medical products at an early stage. This recognition of quality control saves Switzerland’s pharmaceutical industry between 130-300 million Swiss francs yearly when trading with the EU, the EFTA States and Canada.

In addition, a single central authority, the Federal Coordination Centre for Biotechnology governs all biotech and gene tech licensing applications which leads to a minimalistic and streamlined bureaucracy procedure.

Switzerland continues to rank number one on the Global Innovation Index due to its access to expert workforces, supportive governmental laws and its relation to the global trading market. Switzerland remains an attractive place to live and work, especially in such an important industry to Switzerland’s nationality and GDP as the pharmaceutical industry.

Work in Switzerland’s pharmaceutical industry

Now that you know more about the exciting contributions Switzerland has made in the history of the pharmaceutical industry, consider landing your next role in this booming industry and innovative country with Swisslinx. We also recruit talented pharmaceutical candidates to work in pharmaceutical hotspots worldwide. Contact us for more information or apply for your next role with Swisslinx today.

Swisslinx recognised as Best Supplier for the second year in a row

We’re delighted to announce that Swisslinx were once again awarded Best Supplier 2018 for the Roche HTS MSP program. As these roles are challenging to source and most positions are distributed to more than 10 suppliers on this account, this recognition is a huge achievement for us – particularly as it was our second year in a row to win.   The award is significant as the suppliers involved all have an even playing field when sourcing for the roles, most of which require a mix of both life sciences and IT knowledge. This is a niche skillset and the talent pool tends to be limited, which means there is huge competition for every position. While the roles can be difficult to source, we gave every position utmost priority and threw ourselves into the challenge. This included incorporating previous managers’ candidate feedback into our search criteria, treating our candidates fairly and maintaining professionalism and discretion at every step. Our reputation as a reliable, top-tier consultancy means we receive high calibre referrals for candidates we can place in the future.   Winning the accolade comes at an exciting time for our consultancy and contributes to our continued success in the ever-expanding healthcare & life sciences IT market. In today’s data-centred economy, our life sciences IT team is particularly busy sourcing and attracting the best talent in the field to enable our clients to use data to save and improve lives. We’re proud of our success in the hotly contested battle and would like to congratulate our fellow suppliers on what was a successful year for the program.   About Swisslinx’s Healthcare and Life Sciences team   Our Healthcare and Life Sciences team is active with clients all over Switzerland and focuses on the Commercial and Research and Development units in addition to our IT coverage. In the last 12 months we have completed four major projects for firms relocating offices to Switzerland, from talent mapping and compensation benchmarking through to search and selection and advising on employment contracts.     Are you a candidate looking for a job in healthcare and life sciences IT or a manager looking to add talent in your team? Then please contact us to start a conversation. 

READ MORE

Doing business in Zurich: Trends to watch out for

Doing business in Zurich: Trends to watch out for Since being named as the world’s most sustainable city in 2016, Zurich hasn’t rested on its laurels, continuing to flourish as a place to both live and work. The social, environmental, and economic factors that led to the award are things that the city has long been revered for, but it’s not something that’s happened by accident. With a desire to maintain its reputation as a “centre of economic life and education” (a line coined by the official tourist site myswitzerland.com), investment in Zurich’s local infrastructure continues at pace, while being conscious of its environmental impact; the city is one of the lowest generators of emissions and consumers of water in Europe. Why Zurich attracts businesses and people While it’s regularly ranked as the second-most competitive financial centre in Europe behind London, uncertainties around the future of the UK could well play into Zurich’s hands. Already home to 10 of the world’s largest financial firms, the engineering hubs of tech giants and a giant data centre industry, a local startup scene has emerged attracting talent from amongst the 60,000 students who call the city home. While some will naturally be keen to move into an established household name business when they come out of education, the chance to be a part of something new and exciting is just as attractive to the modern workforce. Zurich offers the best of both worlds. Zurich’s low rate of 3.0% unemployment is on a par with the national average, below that of Basel (3.6%) and Geneva (4.9%) and far better than the European average of 6.8%. The business setup is there to cope, no matter how many people want to call the city home! Sensible city planning Of the 425k people who currently call Zurich home, 68% of them are of working age. That’s 2% above the national average in Switzerland and 3% above European averages. Those may sound like small margins, but in a city that’s seen annual population increases of 1.8% over the past decade, it may look from the outside to be a growing city with limited space to expand. In other regions that could create some serious logistical nightmare — over-urbanisation has a habit of pushing the cost of living way up — however, Zurich isn’t just any other city. The planning department at the City of Zurich recognised this trend well before it became a problem, implementing an active policy to make better use of abandoned industrial sites to provide affordable studio spaces and rehearsal rooms. This has seen great redevelopment in Zurich-West, where the former derelict buildings are becoming lively spaces full of contemporary art. Refurbished shipping containers have become pop-up retail spaces and dingy back streets and railway arches now house some of the most desirable restaurants and cafes in the city. Providing a launchpad While Zurich is home to many large corporate financial services organisations, such as UBS, Credit Suisse, Swiss Re and Zurich Insurance, it’s increasingly becoming known for its positive startup environment. Areas like Kreis 5 provide the perfect spot for coworking, and the many meetups, tech conferences and incubator schemes have helped fuel the thriving startup scene. With the close proximity to those making financial decisions, some for these companies can be expected to break out of startup mode in the coming years. Exactly who it will be is a matter for debate, but there are some strong contenders. Of course, the apple doesn’t fall too far from the tree, and within the financial sector companies such as Advanon and Wefox are attempting to challenge the traditional norms of the industry. The medical folk are arguably even more active when it comes to innovation, with Ava becoming a vital service for women across the world, and Versantis, Xeltis and Cutiss showing strength in the pharma and medical devices field. Whether it’s Selfnation in fashion, ComfyLight in home security, Nezasa in travel or Beekeeper in employee communication, every corner of the city has a potential ‘next big thing’ on its hands. For any company considering where to base their HQ, Zurich surely must close to the top of the list. Make your business move with Swisslinx As a specialist recruitment company providing talent solutions across Switzerland and internationally, we’re proud to stay ahead of the curve when it comes to technology and recruitment trends. With a Zurich base, we are active partners to new startups and larger organisations emerging in the city, and have a thriving network of skilled, vetted candidates ready to make their mark in this market. Find out more about what we offer here.

READ MORE